(S)-4-(5-chloro-2-(isopropylamino)pyrimidin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide

ID: ALA4571588

PubChem CID: 155562528

Max Phase: Preclinical

Molecular Formula: C20H21Cl2N5O2

Molecular Weight: 434.33

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)Nc1ncc(Cl)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1

Standard InChI:  InChI=1S/C20H21Cl2N5O2/c1-11(2)25-20-24-9-15(22)18(27-20)13-7-16(23-8-13)19(29)26-17(10-28)12-4-3-5-14(21)6-12/h3-9,11,17,23,28H,10H2,1-2H3,(H,26,29)(H,24,25,27)/t17-/m1/s1

Standard InChI Key:  ZSDNLFAQBBJCBR-QGZVFWFLSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
    3.1559   -1.5188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1548   -2.3383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8628   -2.7473    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5725   -2.3378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5696   -1.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8610   -1.1099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4467   -2.7464    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4461   -3.5635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7381   -3.9716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1535   -3.9727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2758   -1.1039    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.2813   -2.7429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3681   -3.5555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1677   -3.7241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5752   -3.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0273   -2.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3877   -2.9290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8692   -3.5893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7189   -2.1819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6817   -3.5025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1632   -4.1629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0129   -2.7555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8241   -2.6706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1553   -1.9244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6737   -1.2631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8572   -1.3529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5298   -2.0993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9679   -1.8380    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.9757   -4.0761    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  5 11  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
  4 12  1  0
 15 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  1
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 24 28  1  0
 21 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4571588

    ---

Associated Targets(Human)

SW626 (166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WM 266-4 (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.33Molecular Weight (Monoisotopic): 433.1072AlogP: 4.06#Rotatable Bonds: 7
Polar Surface Area: 102.93Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.41CX Basic pKa: 2.11CX LogP: 3.38CX LogD: 3.38
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.45Np Likeness Score: -1.22

References

1. Ji D, Zhang L, Zhu Q, Bai Y, Wu Y, Xu Y..  (2019)  Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.,  164  [PMID:30605831] [10.1016/j.ejmech.2018.12.040]

Source